These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6278174)

  • 1. [Comparison of antibacterial activity of cefmenoxime with other cephalosporins against clinically isolated bacteria (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1981 Oct; 34(10):1366-86. PubMed ID: 6278174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
    Okada K; Kawamura N; Ohkoshi M; Satake Y; Kawakita J
    Jpn J Antibiot; 1982 Apr; 35(4):1009-21. PubMed ID: 6285019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activities of cefotiam against various causative organisms isolated from clinical materials (author's transl)].
    Matsuoka A; Sumi K; Yoshimoto H; Takase M; Takashima S; Mimura K
    Jpn J Antibiot; 1982 Apr; 35(4):993-1003. PubMed ID: 6285029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
    Takahashi C; Miyazawa K
    Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1986 Oct; 39(10):2579-86. PubMed ID: 3100836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K; Uete T
    Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
    Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
    Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antibacterial activity of various cephems against clinical isolates from complicated urinary tract infections].
    Kamidono S; Fujii A; Arakawa S; Kataoka N; Ishigami J
    Jpn J Antibiot; 1985 Jan; 38(1):179-89. PubMed ID: 3989977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
    Tsuji A; Goto S; Sato K; Tomizawa M; Hasebe S; Takagi T; Yatagai S; Kanno H; Ozaki K; Yakata M
    Jpn J Antibiot; 1985 Aug; 38(8):2171-84. PubMed ID: 3908734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basic and clinical studies on cefmenoxime in pediatric field].
    Iwata S; Iwasaki Y; Kanemitsu T; Akita H; Hotta M; Yamashita N; Nanri S; Wakabayashi R; Kojima Y; Sunakawa K; Osano M; Ichihashi Y; Tachibana Y; Takahashi H; Kori T
    Jpn J Antibiot; 1982 Oct; 35(10):2440-9. PubMed ID: 6306295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
    Jpn J Antibiot; 1987 Dec; 40(12):1975-2011. PubMed ID: 3448255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activities of cefotiam against various pathogens isolated from clinical materials (author's transl)].
    Murase M; Niiya T; Katayama Y; Takeuchi N
    Jpn J Antibiot; 1982 Apr; 35(4):1004-8. PubMed ID: 6285018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of antibacterial potencies of oral and parenteral antibiotic preparations against Escherichia coli, Klebsiella, Citrobacter, and Proteus isolated from urinary tract infections (3: 1981). 2. Changes in bacterial sensitivities].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1983 Jun; 36(6):1504-20. PubMed ID: 6361313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of cefoperazone against anaerobic bacteria (author's transl)].
    Imamura H; Kobayashi T; Murata K; Kohbata S; Watanabe I; Marui T; Watanabe K; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1980 Nov; 33(11):1171-82. PubMed ID: 6454011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.